Gestational diabetes mellitus, hypertension, and dyslipidemia as the risk factors of preeclampsia

Farah Aziz,Mohammad Fareed Khan,Amna Moiz
DOI: https://doi.org/10.1038/s41598-024-56790-z
IF: 4.6
2024-03-15
Scientific Reports
Abstract:Gestational diabetes mellitus (GDM) is a known risk factor for gestational hypertension which further progress toward conditions like proteinuria, dyslipidemia, thrombocytopenia, pulmonary edema leading to Preeclampsia (PE). Pregnancy can be a challenging time for many women, especially those diagnosed with GDM and PE. Thus, the current prospective study investigates the association of OGTT glucose levels with systolic and diastolic blood pressure and lipid profile parameters in pregnant women diagnosed with GDM and PE. A total of 140 pregnant women were stratified into GDM (n = 50), PE (n = 40) and controls (n = 50). Two hour 75 g oral glucose tolerance test (OGTT) was performed for screening GDM. Biochemical parameters analysis of OGTT, total cholesterol (TC), triglyceride (Tg), high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C), urinary albumin and creatinine were tested to find urinary albumin creatinine ratio (uACR). Statistical analysis was performed using ANOVA followed by post hoc test and regression analysis. Among the studied groups, GDM and PE groups showed no significant difference in age and increased BMI. Increased 2 h OGTT & TC in GDM group; elevated uACR, systolic/diastolic blood pressure, Tg, HDL-C, LDL-C in PE group was observed and differ significantly ( p < 0.0001) with other groups. A significant positive effect of 2 h OGTT was observed on blood pressure (R 2 : GDM = 0.85, PE = 0.71) and lipid profile determinants (R 2 : GDM = 0.85, PE = 0.33) at p < 0.0001. The current study concludes that glucose intolerance during the later weeks of pregnancy is associated with gestational hypertension and hyperlipidemia as a risk factor for PE. Further research is needed for a detailed assessment of maternal glucose metabolism at various pregnancy stages, including the use of more sensitive markers such as C-peptide and their relation to pregnancy-related hypertensive disorders.
multidisciplinary sciences
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to explore the associations between gestational diabetes mellitus (GDM), gestational hypertension and dyslipidemia, and how these factors act as risk factors for pre - eclampsia (PE). Specifically, the study aims to evaluate whether glucose intolerance in the late pregnancy is related to gestational hypertension and hyperlipidemia by analyzing the relationships between blood - glucose levels in the oral glucose tolerance test (OGTT) and blood - pressure and blood - lipid parameters, so as to further understand the roles of these factors in the pathogenesis of pre - eclampsia. The research background indicates that gestational diabetes mellitus and pre - eclampsia are common pregnancy - related problems, which pose threats to the health of the mother and the fetus. Gestational diabetes mellitus is characterized by glucose intolerance first diagnosed during pregnancy, while pre - eclampsia is manifested by symptoms such as hypertension and proteinuria after 20 weeks of pregnancy. Both are involved in oxidative stress, release of pro - inflammatory factors and vascular endothelial dysfunction in pathophysiological mechanisms, which jointly increase the mother's risk of diabetes and cardiovascular diseases in the future, suggesting that there is a connection between gestational diabetes mellitus and pre - eclampsia. The research methods include grouping 140 pregnant women (GDM group, PE group and control group), and exploring the differences among the groups and their relationships with blood - pressure and blood - lipid parameters through OGTT tests, blood biochemical index analyses (such as total cholesterol, triglycerides, high - density lipoprotein cholesterol, low - density lipoprotein cholesterol, etc.) and statistical analyses (ANOVA, regression analysis, etc.). The research results show that the blood - glucose levels 2 hours after OGTT, urine albumin - to - creatinine ratio (uACR), systolic/diastolic blood pressure, triglycerides, high - density lipoprotein cholesterol and low - density lipoprotein cholesterol in the GDM and PE groups are significantly higher than those in the control group. In addition, the blood - glucose levels 2 hours after OGTT have a significant positive impact on blood pressure (in the GDM group, \(R^2 = 0.85\), in the PE group, \(R^2 = 0.71\)) and blood - lipid parameters (in the GDM group, \(R^2 = 0.85\), in the PE group, \(R^2 = 0.33\)). The conclusion part emphasizes that glucose intolerance in the late pregnancy is related to gestational hypertension and hyperlipidemia, and these factors may be risk factors for pre - eclampsia. Future research needs to evaluate the maternal glucose metabolism in different pregnancy stages more detailedly, and consider using more sensitive markers (such as C - peptide) and their relationships with pregnancy - related hypertensive diseases.